Back to Authors

Karp, C.

Mayo Clinic

Prothena (United States)

Citations 1

P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES

HemaSphere | May 11, 2023 | Volume: 7 | Issue: S2 | Pages: 41-42

10.1097/01.hs9.0000936352.84768.4d